The melatonin market size has grown strongly in recent years. It will grow from $1.88 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to a rise in sleep disorder cases, heightened stress and anxiety levels, greater awareness of sleep health, increasing demand from the aging population, and growing interest in natural supplements.
The melatonin market size is expected to see strong growth in the next few years. It will grow to $2.77 billion in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to a stronger emphasis on preventive healthcare, an increasing prevalence of dietary deficiencies, rising demand for plant-based supplements, the growing impact of social media marketing, and increased popularity among both children and the elderly. Key trends expected during this period include progress in sleep science research, the incorporation of melatonin into skincare products, technology-enabled personalized dosing solutions, advancements in pediatric sleep aid formulations, and the integration of melatonin with wearable sleep tracking devices.
The increasing prevalence of insomnia is expected to drive the growth of the melatonin market in the coming years. Insomnia is a sleep disorder marked by difficulty falling asleep, staying asleep, or waking up too early and being unable to return to sleep, despite having the opportunity to rest. The rise in insomnia cases can be attributed to heightened stress levels, excessive screen usage, irregular sleep schedules, aging populations, and an increase in chronic health conditions. Melatonin plays a key role in managing insomnia by helping regulate the body’s sleep-wake cycle, thereby aiding in both falling asleep and staying asleep, particularly when circadian rhythms are disrupted. For example, in November 2023, Statistics Netherlands - a government agency based in the Netherlands - reported that 22.3% of individuals aged 12 to 24 experienced sleep problems in 2022, up from 19.4% in 2021. Hence, the rising incidence of insomnia is contributing to the expansion of the melatonin market.
Leading companies in the melatonin market are prioritizing the development of innovative technologies, such as three-in-one tablet-in-capsule systems, to improve controlled release, enhance absorption efficiency, and offer extended sleep support for improved consumer benefits. This three-in-one tablet-in-capsule technology involves placing three separate tablets within a single capsule, allowing ingredients to be released at different intervals, thereby enhancing absorption and making the treatment more effective and user-friendly. For example, in September 2023, Ritual, a wellness company based in the US, introduced a new melatonin supplement utilizing its advanced BioSeries technology - a three-phase release mechanism contained in one capsule. This system delivers melatonin in timed stages that align with the body’s natural sleep-wake rhythm, promoting faster sleep onset, sustained restful sleep, and a refreshed feeling upon waking.
In May 2023, Adalvo Limited, a pharmaceutical company based in Malta, entered into a partnership with EQL Pharma to expand the global presence and commercialization of Mellozzan, a melatonin-based product. Under this collaboration, Adalvo will leverage its regulatory expertise and vast distribution network covering 89 countries, allowing EQL Pharma to concentrate on manufacturing and supply operations. EQL Pharma is a Sweden-based pharmaceutical company that focuses on the development, marketing, and sales of generic and specialty medications.
Major players in the melatonin market are Church & Dwight Co. Inc., Herbalife Nutrition Ltd, Zenith Nutrition, Amway Corporation, Aurobindo Pharma, Aspen Holdings, NU SKIN, GNC Holdings LLC, Pharmavite, Jameison Wellness, Rexall Sundown Inc., Nature's Way Brands LLC, Schiff Nutrition International, Natrol LLC, Solgar Inc., Biotics Research Corporation, Herbaland, Lactonova, Prime Health Ltd., and Zebra CBD.
North America was the largest region in the melatonin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in melatonin report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the melatonin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Melatonin is a naturally occurring hormone produced by the pineal gland in the brain that plays a key role in regulating the body’s sleep-wake cycle, also known as the circadian rhythm. It is commonly used in supplement form to promote sleep, particularly for issues like insomnia or jet lag, by signaling the body that it is time to rest.
Melatonin is primarily available in two forms including natural and synthetic. Natural melatonin, which is produced by the pineal gland to regulate the sleep-wake cycle, can also be derived from natural extracts for use in supplements. Melatonin products are available in a range of formats, including tablets, capsules, liquid forms, gummies, and sublingual tablets. Treatment options include dietary supplements and, in some instances, pharmaceutical preparations. Melatonin is used to address insomnia, manage jet lag and other sleep disorders, relieve stress, and help maintain circadian rhythm balance. These products are widely sold through online platforms, pharmacies, health food outlets, supermarkets, hypermarkets, and specialty retail stores.
The melatonin market research report is one of a series of new reports that provides melatonin market statistics, including the melatonin industry global market size, regional shares, competitors with the melatonin market share, detailed melatonin market segments, market trends, and opportunities, and any further data you may need to thrive in the melatonin industry. This melatonin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The melatonin market consists of sales of patches, sprays, combination sleep aids, and lozenges. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The melatonin market size is expected to see strong growth in the next few years. It will grow to $2.77 billion in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to a stronger emphasis on preventive healthcare, an increasing prevalence of dietary deficiencies, rising demand for plant-based supplements, the growing impact of social media marketing, and increased popularity among both children and the elderly. Key trends expected during this period include progress in sleep science research, the incorporation of melatonin into skincare products, technology-enabled personalized dosing solutions, advancements in pediatric sleep aid formulations, and the integration of melatonin with wearable sleep tracking devices.
The increasing prevalence of insomnia is expected to drive the growth of the melatonin market in the coming years. Insomnia is a sleep disorder marked by difficulty falling asleep, staying asleep, or waking up too early and being unable to return to sleep, despite having the opportunity to rest. The rise in insomnia cases can be attributed to heightened stress levels, excessive screen usage, irregular sleep schedules, aging populations, and an increase in chronic health conditions. Melatonin plays a key role in managing insomnia by helping regulate the body’s sleep-wake cycle, thereby aiding in both falling asleep and staying asleep, particularly when circadian rhythms are disrupted. For example, in November 2023, Statistics Netherlands - a government agency based in the Netherlands - reported that 22.3% of individuals aged 12 to 24 experienced sleep problems in 2022, up from 19.4% in 2021. Hence, the rising incidence of insomnia is contributing to the expansion of the melatonin market.
Leading companies in the melatonin market are prioritizing the development of innovative technologies, such as three-in-one tablet-in-capsule systems, to improve controlled release, enhance absorption efficiency, and offer extended sleep support for improved consumer benefits. This three-in-one tablet-in-capsule technology involves placing three separate tablets within a single capsule, allowing ingredients to be released at different intervals, thereby enhancing absorption and making the treatment more effective and user-friendly. For example, in September 2023, Ritual, a wellness company based in the US, introduced a new melatonin supplement utilizing its advanced BioSeries technology - a three-phase release mechanism contained in one capsule. This system delivers melatonin in timed stages that align with the body’s natural sleep-wake rhythm, promoting faster sleep onset, sustained restful sleep, and a refreshed feeling upon waking.
In May 2023, Adalvo Limited, a pharmaceutical company based in Malta, entered into a partnership with EQL Pharma to expand the global presence and commercialization of Mellozzan, a melatonin-based product. Under this collaboration, Adalvo will leverage its regulatory expertise and vast distribution network covering 89 countries, allowing EQL Pharma to concentrate on manufacturing and supply operations. EQL Pharma is a Sweden-based pharmaceutical company that focuses on the development, marketing, and sales of generic and specialty medications.
Major players in the melatonin market are Church & Dwight Co. Inc., Herbalife Nutrition Ltd, Zenith Nutrition, Amway Corporation, Aurobindo Pharma, Aspen Holdings, NU SKIN, GNC Holdings LLC, Pharmavite, Jameison Wellness, Rexall Sundown Inc., Nature's Way Brands LLC, Schiff Nutrition International, Natrol LLC, Solgar Inc., Biotics Research Corporation, Herbaland, Lactonova, Prime Health Ltd., and Zebra CBD.
North America was the largest region in the melatonin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in melatonin report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the melatonin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Melatonin is a naturally occurring hormone produced by the pineal gland in the brain that plays a key role in regulating the body’s sleep-wake cycle, also known as the circadian rhythm. It is commonly used in supplement form to promote sleep, particularly for issues like insomnia or jet lag, by signaling the body that it is time to rest.
Melatonin is primarily available in two forms including natural and synthetic. Natural melatonin, which is produced by the pineal gland to regulate the sleep-wake cycle, can also be derived from natural extracts for use in supplements. Melatonin products are available in a range of formats, including tablets, capsules, liquid forms, gummies, and sublingual tablets. Treatment options include dietary supplements and, in some instances, pharmaceutical preparations. Melatonin is used to address insomnia, manage jet lag and other sleep disorders, relieve stress, and help maintain circadian rhythm balance. These products are widely sold through online platforms, pharmacies, health food outlets, supermarkets, hypermarkets, and specialty retail stores.
The melatonin market research report is one of a series of new reports that provides melatonin market statistics, including the melatonin industry global market size, regional shares, competitors with the melatonin market share, detailed melatonin market segments, market trends, and opportunities, and any further data you may need to thrive in the melatonin industry. This melatonin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The melatonin market consists of sales of patches, sprays, combination sleep aids, and lozenges. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Melatonin Market Characteristics3. Melatonin Market Trends And Strategies4. Melatonin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market32. Global Melatonin Market Competitive Benchmarking And Dashboard33. Key Mergers And Acquisitions In The Melatonin Market34. Recent Developments In The Melatonin Market
5. Global Melatonin Growth Analysis And Strategic Analysis Framework
6. Melatonin Market Segmentation
7. Melatonin Market Regional And Country Analysis
8. Asia-Pacific Melatonin Market
9. China Melatonin Market
10. India Melatonin Market
11. Japan Melatonin Market
12. Australia Melatonin Market
13. Indonesia Melatonin Market
14. South Korea Melatonin Market
15. Western Europe Melatonin Market
16. UK Melatonin Market
17. Germany Melatonin Market
18. France Melatonin Market
19. Italy Melatonin Market
20. Spain Melatonin Market
21. Eastern Europe Melatonin Market
22. Russia Melatonin Market
23. North America Melatonin Market
24. USA Melatonin Market
25. Canada Melatonin Market
26. South America Melatonin Market
27. Brazil Melatonin Market
28. Middle East Melatonin Market
29. Africa Melatonin Market
30. Melatonin Market Competitive Landscape And Company Profiles
31. Melatonin Market Other Major And Innovative Companies
35. Melatonin Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Melatonin Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on melatonin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for melatonin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The melatonin market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Natural Melatonin; Synthetic Melatonin2) By Product Type: Tablets; Capsules; Liquid Solutions; Gummies; Sublingual Tablets
3) By Treatment Type: Dietary Supplements; Pharmaceuticals
4) By Application: Insomnia Treatment; Jet Lag Management; Sleep Disorders; Stress Relief; Circadian Rhythm Regulation
5) By Distribution Channel: Online Retailers; Pharmacies; Health Food Stores; Supermarkets; Hypermarkets; Specialty Stores
Subsegments:
1) By Natural Melatonin: Plant-Based Melatonin; Animal-Based Melatonin2) By Synthetic Melatonin: Prescription-Based Synthetic Melatonin; Over-the-Counter (OTC) Synthetic Melatonin
Key Companies Profiled: Church & Dwight Co. Inc.; Herbalife Nutrition Ltd; Zenith Nutrition; Amway Corporation; Aurobindo Pharma
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Church & Dwight Co. Inc.
- Herbalife Nutrition Ltd
- Zenith Nutrition
- Amway Corporation
- Aurobindo Pharma
- Aspen Holdings
- NU SKIN
- GNC Holdings LLC
- Pharmavite
- Jameison Wellness
- Rexall Sundown Inc.
- Nature's Way Brands LLC
- Schiff Nutrition International
- Natrol LLC
- Solgar Inc.
- Biotics Research Corporation
- Herbaland
- Lactonova
- Prime Health Ltd.
- Zebra CBD.